You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lymphangioma

Showing 1 - 25 of 53
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphangioma Trial in Albuquerque (Alpelisib)

Available
  • Lymphangioma
  • Albuquerque, New Mexico
    University of New Mexico - Cancer Center
Oct 4, 2022

Venous Malformation, Lymphatic Malformation Trial in Charleston (Sirolimus)

Recruiting
  • Venous Malformation
  • Lymphatic Malformation
  • Charleston, South Carolina
    Medical University of South Carolina
Nov 7, 2022

Slow-Flow Vascular Malformation, Fast-Flow Vascular Malformation, Vascular Malformations Trial in Parkville (Alpelisib,

Not yet recruiting
  • Slow-Flow Vascular Malformation
  • +17 more
  • Parkville, Victoria, Australia
    The Royal Children's Hospital
Aug 7, 2023

Lymphatic Malformations Trial (Alpelisib, Placebo)

Not yet recruiting
  • Lymphatic Malformations
  • (no location specified)
Jul 4, 2023

Kaposiform Hemangioendothelioma, Tufted Angioma, Superficial Vascular Anomalies Trial in Shanghai (Percutaneous sirolimus, Oral

Recruiting
  • Kaposiform Hemangioendothelioma
  • +3 more
  • Percutaneous sirolimus
  • Oral sirolimus
  • Shanghai, China
    Children's Hospital of Fudan University
Jan 9, 2023

Lymphatic Malformation Trial (TARA-002)

Not yet recruiting
  • Lymphatic Malformation
  • TARA-002
  • (no location specified)
May 22, 2023

Lymphatic Malformation, Generalized Lymphatic Anomaly (GLA), Central Conducting Lymphatic Anomaly Trial in Boston

Recruiting
  • Lymphatic Malformation
  • +9 more
    • Boston, Massachusetts
      Boston Children's Hospital
    Sep 8, 2022

    Vascular Malformations, Vascular Anomaly, Hemangioma Trial in Rochester (Percutaneous Vascular Anomaly/Malformation Biopsy)

    Completed
    • Vascular Malformations
    • +6 more
    • Percutaneous Vascular Anomaly/Malformation Biopsy
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Apr 20, 2022

    Patients With PIK3CA-Related Overgrowth Spectrum (PROS)

    Not yet recruiting
    • PIK3CA-related Overgrowth Spectrum
    • +8 more
    • national registry
    • Paris, France
      Translational medicine and Targeted therapies unit, Hôpital Neck
    Sep 28, 2022

    Lymphatic Malformations, Lymphatic Diseases Trial in Stanford, Aurora, Chicago (Sildenafil 20 mg tablets, Placebo tablets

    Completed
    Has Results
    • Lymphatic Malformations
    • Lymphatic Diseases
    • Sildenafil 20 mg tablets
    • Placebo tablets (resembling Revatio)
    • Stanford, California
    • +2 more
    Oct 25, 2022

    Lingual Microcystic Lymphatic Malformations Trial in Tours, Orléans, Paris (Sirolimus Oral Liquid Product 1mg/mL)

    Recruiting
    • Lingual Microcystic Lymphatic Malformations
    • Sirolimus Oral Liquid Product 1mg/mL
    • Tours, Indre Et Loire, France
    • +2 more
    Mar 3, 2022

    Microcystic Lymphatic Malformation Trial in United States (PTX-022)

    Recruiting
    • Microcystic Lymphatic Malformation
    • Little Rock, Arkansas
    • +5 more
    Feb 25, 2022

    Vascular Malformations, Lymphatic Malformation Trial in France (Topical 0.1% Sirolimus, Topical Vehicle)

    Recruiting
    • Vascular Malformations
    • Lymphatic Malformation
    • Topical 0.1% Sirolimus
    • Topical Vehicle
    • Angers, France
    • +16 more
    Sep 29, 2021

    Lymphatic Malformations Trial in United States (OK432)

    Completed
    Has Results
    • Lymphatic Malformations
    • San Diego, California
    • +13 more
    Oct 27, 2021

    Lymphatic Disorders Trial in Beijing (68Ga-NEB)

    Recruiting
    • Lymphatic Disorders
    • Beijing, Beijing, China
      Peking Union Medical College Hospital, Chinese Academy of Medica
    Feb 15, 2020

    Airway Vascular Lesions

    Completed
    • Hemangiomas
    • +2 more
    • Protocols for Treatment
    • (no location specified)
    Jan 10, 2019

    Asthma Trial (montelukast, Comparator: Placebo)

    Completed
    Has Results
    • Asthma
    • (no location specified)
    Jan 31, 2022

    AVAST Anomalies Vasculaires Associées au Syndrome de Turner

    Active, not recruiting
    • Turner Syndrome
    • +3 more
    • Echo doppler
    • Besancon, France
    • +5 more
    Jun 28, 2022

    Rheumatoid Arthritis Trial (CT-P10, Rituxan, MabThera)

    Completed
    Has Results
    • Rheumatoid Arthritis
    • CT-P10
    • +2 more
    • (no location specified)
    Nov 18, 2021

    Pediatric Hydroxyurea Phase III Clinical Trial Follow-up

    Completed
    Has Results
    • Sickle Cell Anemia
    • Birmingham, Alabama
    • +13 more
    Aug 10, 2020

    Ongoing Pregnancies Established in Clinical Trial P05787

    Completed
    Has Results
    • Pregnancy
    • Neonates
    • Corifollitropin Alfa 150 μg
    • +7 more
    • (no location specified)
    Feb 1, 2022

    Dengue, Dengue Fever, Dengue Hemorrhagic Fever Trial in Worldwide (Live, attenuated, dengue serotype 1, 2, 3, 4 virus, Placebo:

    Completed
    Has Results
    • Dengue
    • +2 more
    • Live, attenuated, dengue serotype 1, 2, 3, 4 virus
    • Placebo: Sodium chloride (NaCl) 0.9%
    • Denpasar, Bali, Indonesia
    • +11 more
    Mar 10, 2022

    Diphtheria, Tetanus, Poliomyelitis Trial in Singapore (GSK Biologicals' combined DTPa-IPV/Hib vaccine)

    Completed
    Has Results
    • Diphtheria
    • +5 more
    • GSK Biologicals' combined DTPa-IPV/Hib vaccine
    • Singapore, Singapore
      GSK Investigational Site
    Dec 26, 2019

    Venous Thromboembolism Trial in Worldwide (Rivaroxaban (Xarelto, BAY59-7939), Standard of Care)

    Completed
    Has Results
    • Venous Thromboembolism
    • Rivaroxaban (Xarelto, BAY59-7939)
    • Standard of Care
    • Phoenix, Arizona
    • +108 more
    Mar 13, 2020

    Diabetes, Type 2 Trial in Japan (empagliflozin 10 mg + linagliptin 5 mg, empagliflozin 10 mg, empagliflozin 25 mg + linagliptin

    Completed
    Has Results
    • Diabetes Mellitus, Type 2
    • empagliflozin 10 mg + linagliptin 5 mg
    • +4 more
    • Aichi, Kasugai, Japan
    • +82 more
    Sep 3, 2018